Alexandre P. Diaz1,2*
, Brisa S. Fernandes1,2*
, Joao Quevedo1,2,3,4
, Marsal Sanches1
, Jair C. Soares1,3
DOI: 10.1590/1516-4446-2020-1627
Epub: 21 de Maio de 2021
1Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
2Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
3Neuroscience Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA
4Laboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
Alexandre Paim Diaz, Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, UTHealth School of Medicine, 1941 East Road, Suite 3130, Houston, Texas, USA, 77054. E-mail: Alexandre.PaimDiaz@uth.tmc.edu